Home - Products - Membrane Transporter/Ion Channel - Sodium Channel - Nav1.7 inhibitor

Nav1.7 inhibitor

CAS No. 1355631-24-1

Nav1.7 inhibitor( —— )

Catalog No. M33035 CAS No. 1355631-24-1

Nav1.7 inhibitor is a Nav1.7 inhibitor for research in the field of pain and anesthesia.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	89	In Stock
2MG	50	In Stock
5MG	82	In Stock
10MG	138	In Stock
25MG	278	In Stock
50MG	436	In Stock
100MG	700	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Nav1.7 inhibitor
Note

Research use only, not for human use.
Brief Description

Nav1.7 inhibitor is a Nav1.7 inhibitor for research in the field of pain and anesthesia.
Description

Nav1.7 inhibitor (compound II), a sulfonamide, is a potent Nav1.7 inhibitor. Nav1.7 inhibitor has the potential for a wide range of disorders, particularly pain.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Membrane Transporter/Ion Channel
Target

Sodium Channel
Recptor

Sodium Channel
Research Area

——
Indication

——

Chemical Information

CAS Number

1355631-24-1
Formula Weight

426.68
Molecular Formula

C15H11Cl3FNO4S
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : ≥ 100 mg/mL (234.37 mM )
SMILES

O=C(NS(=O)(=O)C)C=1C=C(Cl)C(=CC1F)COC2=CC=C(Cl)C(Cl)=C2
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Alan Daniel Brown, et al. Preparation of sulfonamide derivatives as Nav1.7 inhibitors. Patent WO2012007868A2.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

SPX-101

SPX-101 is a specific, peptide mimetic promoter of epithelial sodium channel (ENaC) internalization.
Propoxycaine hydroch...

Propoxycaine hydrochloride, an ester local anesthetic, inhibits voltage-gated sodium channels, modulates nerve impulses, and can induce sensory loss.
AZD 7009 B

AZD 7009 is a novel antiarrhythmic compound that inhibits the sodium current of hNav1.5 in CHO K1 cells with an IC50 of 11 uM.

Sign In Join Free